VERA SCHEDULE 13G/A: SEC filing

Avoro Capital Advisors LLC

Filed with the SEC on · accession 0000902664-26-004552

VERA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Avoro Capital Advisors LLC filed an amended Schedule 13G reporting beneficial ownership of 5,635,000 shares, or 7.82%, of Vera Therapeutics Class A Common Stock as of September 30, 2026.

Summary of the filing

Avoro Capital Advisors LLC filed an amended Schedule 13G reporting beneficial ownership of 5,635,000 shares, or 7.82%, of Vera Therapeutics Class A Common Stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.

Key details

Shares of Class A Common Stock beneficially owned$5.6M
Percentage of class beneficially ownedPCT 8
Reporting person / beneficial ownerAvoro Capital Advisors LLC
IssuerVera Therapeutics, Inc.
Fund for which shares are heldAvoro Life Sciences Fund LLC
Portfolio manager and controlling person of avoro capital advisors llcBehzad Aghazadeh
Chief operating officer & chief compliance officer, avoro capital advisors llcScott Epstein

✦ Ask GOAX AI about this filing — what it means for VERA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VERA?

Click here

Frequently asked questions

What did VERA file with the SEC on Nov 16, 2026?

VERA filed a SCHEDULE 13G/A (SEC filing). Avoro Capital Advisors LLC filed an amended Schedule 13G reporting beneficial ownership of 5,635,000 shares, or 7.82%, of Vera Therapeutics Class A Common Stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other VERA SEC filings

Get alerts when VERA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days